Los Angeles Capital Management
AVXL icon

Los Angeles Capital Management’s Anavex Life Sciences AVXL Stock Holding History

Los Angeles Capital Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.93K Hold
627
– – ﹤0.01% 2292
2025
Q4 		$5.04K Buy
+627
New +$3.84K ﹤0.01% 2279
2024
Q3 		– Sell
-22,077
Closed -$93.2K – 1173
2024
Q2 		$93.2K Sell
22,077
-65,854
-75% -$266K ﹤0.01% 1153
2024
Q1 		$448K Buy
87,931
+29,844
+51% +$168K ﹤0.01% 909
2023
Q4 		$541K Buy
58,087
+37,867
+187% +$261K ﹤0.01% 847
2023
Q3 		$132K Buy
+20,220
New +$161K ﹤0.01% 1083
2022
Q4 		– Sell
-14,599
Closed -$151K – 1191
2022
Q3 		$151K Buy
+14,599
New +$154K ﹤0.01% 1191

Other funds holding AVXL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM